BCAB - BioAtla, Inc.
4.59
-0.320 -6.972%
Share volume: 27,975
Last Updated: 04-17-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.23%
PREVIOUS CLOSE
CHG
CHG%
$4.91
-0.32
-0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-08-2024 | 11-07-2024 | 03-27-2025 | 05-06-2025 | 11-13-2025 | |
| Assets | |||||||
| Total Assets | 89.197 M | 68.638 M | 62.236 M | 52.422 M | 38.290 M | 15.908 M | |
| Current Assets | 86.425 M | 66.493 M | 60.567 M | 51.232 M | 37.537 M | 9.670 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 80.630 M | 61.662 M | 56.516 M | 49.046 M | 32.363 M | 8.320 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.363 M | 1.134 M | 906.000 K | 678.000 K | 495.000 K | 324.000 K | |
| Other Assets | 1.409 M | 1.011 M | 763.000 K | 512.000 K | 258.000 K | 5.914 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 89.197 M | 68.638 M | 62.236 M | 52.422 M | 38.290 M | 15.908 M | |
| Total liabilities | 39.481 M | 37.268 M | 39.268 M | 38.157 M | 37.743 M | 47.145 M | |
| Total current liabilities | 19.260 M | 17.462 M | 19.462 M | 14.540 M | 16.006 M | 17.984 M | |
| Accounts Payable | 17.751 M | 15.800 M | 18.211 M | 13.704 M | 15.452 M | 16.811 M | |
| Other liabilities | 20.221 M | 19.806 M | 19.806 M | 23.617 M | 21.737 M | 29.161 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 20.221 M | 19.806 M | 19.806 M | 23.617 M | 21.737 M | 29.161 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 49.716 M | 31.370 M | 22.968 M | 14.265 M | 547.000 K | -31.237 M | |
| Common stock | 489.213 M | 491.939 M | 494.123 M | 500.304 M | 501.920 M | 504.625 M | |
| Retained earnings | -439.497 M | -460.569 M | -471.155 M | -486.039 M | -501.373 M | -535.862 M |